CN Patent

CN105085474A — 鲁顿酪氨酸激酶抑制剂

Assigned to Capital Pharmaceutical Holdings (beijing) Co Ltd · Expires 2015-11-25 · 10y expired

What this patent protects

本发明涉及式(III)的化合物或其药学上可接受的盐、溶剂化物、活性代谢物、多晶型物、酯、异构体或前药，包含式(III)的化合物的药物组合物及其作为选择性布鲁顿酪氨酸激酶的不可逆抑制剂用于预防或治疗炎症、与异常B细胞增殖相关的自身免疫性疾病(如类风湿关节炎)和癌症的用途。

USPTO Abstract

本发明涉及式(III)的化合物或其药学上可接受的盐、溶剂化物、活性代谢物、多晶型物、酯、异构体或前药，包含式(III)的化合物的药物组合物及其作为选择性布鲁顿酪氨酸激酶的不可逆抑制剂用于预防或治疗炎症、与异常B细胞增殖相关的自身免疫性疾病(如类风湿关节炎)和癌症的用途。

Drugs covered by this patent

Patent Metadata

Patent number: CN105085474A
Jurisdiction: CN
Classification: —
Expires: 2015-11-25
Drug substance claim: No
Drug product claim: No
Assignee: Capital Pharmaceutical Holdings (beijing) Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.